Posters

 P01 Modulation of pain, muscle energy metabolism and muscle mass in a collagen induced arthritis model in the rat
Nuria Casanova Vallve, UK
P02 Experience with tofacitinib at the Institut de Rhumatologie de Montréal and the Centre d’Ostéoporose et de Rhumatologie de Québec. An analysis from the Rhumadata® clinical database and registry
Denis Choquette, Canada
P03 Injection site reaction (pain) associated with subcutaneous (SC) biologic agents and methotrexate. An analysis from the Rhumadata® clinical database and registry
Denis Choquette, Canada
P04 Musculoskeletal involvements in systemic lupus erythematosus
Kok Yong Fong, Singapore
P05 Influence of affected other joints in lower limbs associated with outcomes of total hip arthroplasty in rheumatoid arthritis
Takashi Imagama, Japan
P06 Role of CCR7 ligands CCL19 and CCL21 in rheumatoid arthritis and osteoclast activity
Hong-Hee Kim, Korea
P07 A single-center two-year prospective observational study for discontinuation of  biologics in forty patients with rheumatoid arthritis: Analysis of coincidence rate of affected joints at relapse
Hiroi Kusaka, Japan
P08 Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in a murine rheumatoid arthritis model
Zang Hee Lee, Korea
P09 20 years of experience with methotrexate in rheumatoid arthritis. An analysis from the Rhumadata® clinical database and registry
Jean-Pierre Raynauld, Canada
P10  20 years of experience with methotrexate in psoriatic arthritis. An analysis from the Rhumadata® clinical database and registry
Jean-Pierre Raynauld, Canada
P11 NAMPT is an essential catabolic regulator of RA-mediated periodontal inflammation
Jehwang Ryu, Korea
P12 Long term result of patellar non-resurfacing in total knee arthroplasty for rheumatoid arthritis
Kazushige Seki, Japan
P13 Morning stiffness in patients with rheumatoid arthritis: Investigating the relationship by ultrasonography
Kazushige Seki, Japan
P14 Skin lesions as a result of biologic treatment in patients with RA and AS
Piotr Wiland, Poland
P15 Assesing sleep quality by patients with rheumatoid arthritis and osteoarthritis
Piotr Wiland, Poland
P16 Heavy lifting and impact training for bone health does not provoke symptoms of knee or hip osteoarthritis:  Preliminary findings from the MOAST trial
Belinda Beck, Australia
P17 Development of an Australian clinical care standard for osteoarthritis of the knee to promote consistency in the management of knee pain due to osteoarthritis
Rachelle Buchbinder, Australia
P18 Accelerated development of aging-associated and instability-induced osteoarthritis in 12/15-lipoxygenase deficient mice
Loures Habouri, Canada
P19 Calcium-phosphate increases MMP3 and MMMP13 through NFkB, p38, Erk1/2 MAP kinase signaling in hypertrophic chondrocyte?
Seungwoo Han, Korea
P20 Influence of Cowpea isoflavones and vitamin D in stimulating the osteogenic gene expression for the treatment of osteoporosis using MG-63 human osteosarcoma cell lines
Rishika Jadai, India
P21 Gene expression profiling for confirmation of effects of DNA polymeric molecules on in vitro arthritis model
Hyun Jung Kim, Korea
P22 Microcurrent as a preventive and therapeutic treatment for calf muscle atrophy in immobilized rabbit
Dong Rak Kwon, Korea
P23 Labisia pumila protects cartilage degradation in cartilage explant and postmenopausal rat models of osteoarthritis
Iffah Nadhira Madzuki, Malaysia
P24 Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by MRI: An exploratory study
Johanne Martel-Pelletier, Canada
P25 In vivo effect of opticin deficiency in a surgically induced mouse model of osteoarthritis
Johanne Martel-Pelletier, Canada
P26 Deletion of the prostaglandin D2 receptor DP1 exacerbates aging-associated and instability-induced osteoarthritis
Yassine Ouhaddi, Canada
P27 Minimally invasive total knee arthroplasty in obese osteoarthritic patients
Sang Hoon Park, Korea
P28 Combination of extramedullary technique and minimally invasive surgery in total knee arthroplasty: Minimum 5 year follow up
Sang Hoon Park, Korea
P29 Do the findings of MRI, arthrography, and ultrasonography reflect clinical impairment in patients with adhesive capsulitis of the shoulder?
Gi-Young Park, Korea
P30 Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: Data from the OAI
Jean-Pierre Pelletier, Canada
P31 Hyaluronic acid(HA) in OA treatment: A canadian consensus
Jean-Pierre Raynauld, Canada
P32 Assessing the quality, reliability and readability of online health information regarding osteoarthritis
Mathew Reynolds, Australia
P33 A comparative evaluation between disease activity in osteoarthritis and serum biomarker cartilage olygomeric matrix protein (COMP) in patients with knee osteoarthritis referred to the Rheumatology Clinic of Sayyad hospital in Gogran in Years 2013-2015
Abolfazl Amjadipour, Iran